Your email has been successfully added to our mailing list.

×
0.000356605119264615 0.00079245582058807 0.000158491164117682 0.000594341865441024 0.00130755210397025 0.00130755210397025 0.00130755210397025 0.00130755210397025
Stock impact report

Eli Lilly Zepbound prescriptions exceed Novo's Wegovy for the first time in U.S. [Seeking Alpha]

IQVIA Holdings, Inc. (IQV) 
Last iqvia holdings, inc. earnings: 4/28 07:00 am Check Earnings Report
US:NYSE Investor Relations: ir.iqvia.com
Company Research Source: Seeking Alpha
therapy Wegovy in terms of new U.S. prescriptions, Reuters reported Friday, citing data from healthcare analytics firm IQVIA ( IQV According to a weekly JPMorgan note, new prescriptions for Lilly's ( LLY ) dual GIP/GLP-1 agonist reached 77,590 for the week ending Mar. 8, compared to 6,000 fewer Wegovy prescriptions filled in the U.S. for that week. However, the Danish drugmaker maintained an overall lead in the weight loss drug market, with Wegovy total weekly prescriptions exceeding those for Zepbound by 25,307. Wegovy and Zepbound, specifically indicated for weight loss in the U.S., are available for monthly list prices of about $1,349 and $1,060, respectively, in a market expected to reach $100B by 2030. Recommended For You More Trending News Recommended For You More Trending News Related Stocks Trending Analysis Trending News Show less Read more
Impact Snapshot
Event Time:
IQV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for IQV alerts
Opt-in for
IQV alerts

from News Quantified
Opt-in for
IQV alerts

from News Quantified